by TractManager | Feb 27, 2023 | Emerging Technology Report
The Corvia Atrial Shunt is a transcatheter interatrial shunt under investigation for treatment of heart failure with preserved or mid-range ejection fraction. If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Feb 24, 2023 | Health Technology Assessment
Focus of the Report: This Health Technology Assessment focuses on evaluating the effectiveness and safety of the LiverMultiScan compared with other imaging and blood marker tests for assessment of liver fibrosis or steatosis in patients who have known or suspected...
by TractManager | Feb 23, 2023 | Emerging Technology Report
The AGN1 Local Osteo-Enhancement Procedure (LOEP) Kit is a resorbable calcium-based implant to improve femoral bone density and strength in postmenopausal patients with osteoporosis. If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Feb 23, 2023 | Emerging Technology Report
Pegcetacoplan (Syfovre; Apellis Pharmaceuticals Inc.) is a complement inhibitor indicated for the treatment of geographic atrophy secondary to age-related macular degeneration.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Feb 22, 2023 | Emerging Technology Report
The Ventura implant is a transcatheter interatrial shunt for treatment of chronic heart failure with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF).If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments